CBC Breast Cancer Treatment & Survivorship Support 2

Question 1

Which of the following is a common long-term side effect of axillary lymph node dissection that breast counselors must educate patients about?

Accepted Answer

Lymphedema

Answer

Cardiac arrhythmia

Answer

Pulmonary embolism

Answer

Alopecia

Question 2

Tamoxifen as endocrine therapy is most commonly prescribed for which patient population?

Accepted Answer

ER-positive premenopausal women

Answer

HER2-positive postmenopausal women

Answer

Triple-negative premenopausal women

Answer

BRCA2-positive women of any menopausal status

Question 3

Which class of endocrine therapy is preferred for postmenopausal women with hormone receptor-positive breast cancer?

Accepted Answer

Aromatase inhibitors

Answer

Selective estrogen receptor modulators (SERMs)

Answer

GnRH agonists

Answer

Progestin-based therapies

Question 4

Which components should be included in a comprehensive survivorship care plan (SCP)?

Accepted Answer

Summary of treatment received, follow-up schedule, and long-term side effect information

Answer

Only the patient's surgical history

Answer

Insurance billing codes for treatments received

Answer

The oncologist's personal dietary recommendations only

Question 5

Chemotherapy-related cognitive impairment ('chemo brain') most commonly affects which cognitive domains?

Accepted Answer

Attention, concentration, and short-term memory

Answer

Long-term memory for past events

Answer

Language comprehension and speech production

Answer

Motor coordination and balance

Question 6

Which recommendation is most appropriate for breast cancer survivors at risk for bone loss during aromatase inhibitor therapy?

Accepted Answer

Take calcium and vitamin D supplements and engage in weight-bearing exercise

Answer

Avoid all weight-bearing exercise to protect bones

Answer

Discontinue aromatase inhibitor therapy immediately if bone density decreases slightly

Answer

Use high-dose estrogen therapy to counteract bone loss

Question 7

How frequently are mammograms typically recommended for breast cancer survivors who have completed treatment?

Accepted Answer

Annually (every year)

Answer

Every 5 years

Answer

Only if new symptoms occur

Answer

Every 2 years after the first post-treatment year